Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants under 48 hours of age born at San Lucas Hospital during study enrollment period~* Infants with gestational age of \> 37 weeks as assessed by neonatologist~* Mother/guardian gives informed consent~* Infant is expected to reside in Puerto Rico for the following 8 months~Exclusion Criteria:~* Mother/guardian does not speak English or Spanish~* Mother/guardian has religious/philosophical objection to immunizations~* Infant has serious chronic or acute health problems that require hospitalization immediately (within 1 day) after birth (assessed by infant not being placed in San Lucas Hospital well-baby clinic)~* Mother expects to travel with infant during study period to a country known to have circulating poliovirus or that uses oral poliovirus vaccine (OPV)

- Gender: ALL
- Minimum Age: 1 Hour
- Maximum Age: 48 Hours
- Healthy Volunteers: t

Study Arms:
- Cohort A-WHO/EPI Schedule (Type: EXPERIMENTAL): Received IPV at ages 6, 10, and 14 weeks (this schedule is also approved for use in the United States if an accelerated schedule is needed.
- Cohort A-US Schedule (Type: ACTIVE_COMPARATOR): Received IPV at ages 8, 16, and 24 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).